These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. 18F-MK-6240 tau-PET in genetic frontotemporal dementia. Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612 [TBL] [Abstract][Full Text] [Related]
12. Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers. Clarke MTM; St-Onge F; Beauregard JM; Bocchetta M; Todd E; Cash DM; Rohrer JD; Laforce R Alzheimers Res Ther; 2021 Feb; 13(1):42. PubMed ID: 33568215 [TBL] [Abstract][Full Text] [Related]
13. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents. Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110 [TBL] [Abstract][Full Text] [Related]
14. Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease. Park EJ; Lyra KP; Lee HW; Caramelli P; Otaduy MCG; Leite CC Dement Neuropsychol; 2010; 4(2):109-113. PubMed ID: 29213672 [TBL] [Abstract][Full Text] [Related]
15. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Whitwell JL; Jack CR; Boeve BF; Senjem ML; Baker M; Ivnik RJ; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Josephs KA Neurology; 2009 Sep; 73(13):1058-65. PubMed ID: 19786698 [TBL] [Abstract][Full Text] [Related]
16. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707 [TBL] [Abstract][Full Text] [Related]
17. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281 [TBL] [Abstract][Full Text] [Related]
19. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study. Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221 [TBL] [Abstract][Full Text] [Related]
20. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers. Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]